Insider Selling: CME Group (NASDAQ:CME) Director Sells $224,400.00 in Stock

CME Group Inc. (NASDAQ:CME) Director Dennis Suskind sold 748 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares in the company, valued at $809,700. This represents a 21.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

CME Group Stock Performance

Shares of CME Group stock opened at $302.48 on Thursday. The firm has a fifty day moving average of $278.61 and a two-hundred day moving average of $273.60. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock has a market capitalization of $109.07 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 3.34 and a beta of 0.27. CME Group Inc. has a 52 week low of $244.43 and a 52 week high of $309.35.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s revenue was up 8.1% on a year-over-year basis. During the same period last year, the company earned $2.52 EPS. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME launched futures for Cardano, Chainlink and Stellar — expanding its crypto product suite and giving institutional traders additional regulated venues, which can drive incremental trading and clearing fees. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures
• Positive Sentiment: CME plans to launch Single Stock futures on 50+ top U.S. names (Alphabet, Meta, NVIDIA, Tesla, etc.), broadening product scope and offering capital-efficient tools for equity exposures — potential long-term fee diversification. CME Group to Launch Single Stock Futures
• Positive Sentiment: Sources say CME is exploring the first-ever rare earths futures contract — a new commodity product that could capture demand tied to EVs, clean energy and defense supply-chain hedging. CME Group plans to launch first rare earths futures contract – Reuters
• Positive Sentiment: Wedbush highlighted strong clearing volumes in CME’s prediction markets around Super Bowl LX — an operational sign that new product adoption is producing meaningful flow spikes. Wedbush Supports CME Group Prediction Markets as Volumes Surge Around Super Bowl LX
• Positive Sentiment: Institutional buying — Illinois Municipal Retirement Fund increased its CME position (~38k shares, ~65% growth vs prior), signaling continued institutional demand. Fund Update: Illinois Municipal Retirement Fund Just Disclosed New Holdings
• Neutral Sentiment: Analyst / earnings follow-ups — Q4 analyst-question coverage and commentary highlight execution and growth drivers but contain no new guidance; useful for modeling but not immediately price-moving. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Neutral Sentiment: Crypto market write-ups note CME’s crypto futures launches as a tailwind for underlying token interest, but crypto price moves are separate from CME’s fee-based revenue. Cardano price forecast: will ADA breakout or decline further from here?
• Negative Sentiment: Insider selling — Director Dennis Suskind sold 748 shares (~$224k); multiple recent insider sales can be interpreted by some investors as a cautionary signal. SEC Form 4: Dennis Suskind sale
• Negative Sentiment: Rising short interest — recent data showed short interest increased to ~5.2M shares (≈1.4% of float, ~2.8 days-to-cover), which can add downward pressure if sentiment deteriorates further.
• Negative Sentiment: Goldman Sachs nudged its price target to $266 but maintained a sell rating — a notable institutional view that may limit near-term buying interest from some investors. The Goldman Sachs Group Increases CME Group Price Target to $266

Institutional Investors Weigh In On CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of CME. Vanguard Group Inc. lifted its stake in shares of CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after buying an additional 588,509 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of CME Group by 3.6% during the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after acquiring an additional 319,899 shares during the period. Norges Bank bought a new position in shares of CME Group during the second quarter worth approximately $1,571,447,000. Bank of New York Mellon Corp lifted its holdings in CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after purchasing an additional 134,242 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in CME Group by 2.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock valued at $1,300,450,000 after purchasing an additional 130,848 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of several recent analyst reports. Bank of America lifted their price objective on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Raymond James Financial cut their target price on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Weiss Ratings reissued a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Barclays upped their price objective on shares of CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Finally, UBS Group reissued a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $297.59.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.